收稿日期: 2023-11-23
网络出版日期: 2024-07-04
基金资助
国家自然科学基金(青年)(81300725)
The correlation between free T3 level and left ventricular diastolic dysfunction in elderly male patients with T2DM
Received date: 2023-11-23
Online published: 2024-07-04
目的:探讨2型糖尿病(type 2 diabetes mellitus, T2DM)老年男性患者的甲状腺激素水平与其左心室舒张功能不全(left ventricular diastolic dysfunction, LVDD)间的相关性。方法:选取2020年1月至2021年11月在我院老年病科住院的208例老年男性T2DM患者(≥60岁),根据超声心动图组织多普勒及血流多普勒结果,参照2020年《超声心动图评估心脏收缩和舒张功能临床应用指南》将其分为LVDD组(112例)和左心室舒张功能正常对照组(对照组,96例),比较2组间的基线资料、甲状腺激素水平、超声心动图指标。再根据游离三碘甲状腺原氨酸(free triiodothyronine, FT3)四分位数水平,将全部患者分为F1组(2.43 pmol/L<FT3≤3.30 pmol/L,52例)、F2组(3.31 pmol/L<FT3≤3.78 pmol/L, 52例)、F3组(3.79 pmol/L<FT3≤4.65 pmol/L, 52例)、F4组(4.66 pmol/L<FT3≤6.01 pmol/L,52例),比较4组间的基线资料和超声心动图指标。采用Pearson相关分析观察FT3与超声指标间的相关性,用多因素logistic回归分析FT3与LVDD间的关系,绘制受试者工作特征(receiver operating characteristic, ROC)曲线,评估FT3和logistic回归模型诊断LVDD的效能。结果:老年男性T2DM患者中,LVDD组较对照组FT3水平降低[(3.51±0.24) pmol/L比(4.72±0.33) pmol/L, P<0.01]。根据FT3水平四分位数分组,4组间的LVDD百分比(P<0.01)、超声心动图参数二尖瓣口舒张早期血流峰值速度E峰与二尖瓣环舒张早期运动峰值速度e’峰比值(E/e’)(P<0.01)差异均有统计学意义。Pearson相关分析显示,FT3水平与E/e’、左房最大容积指数(left atrial volume index,LAVI)呈显著负相关(P均<0.001)。多因素Logistic回归分析显示,随着老年男性T2DM患者的FT3水平递减,其发生LVDD的风险逐渐增加(F3组OR=2.29;F2组OR=3.36;F1组OR=4.95,P均<0.05)。年龄、糖化血红蛋白(glycosylated hemoglobin,HbA1c)水平、糖尿病病程、FT3水平进入Logistic回归分析模型,ROC曲线分析显示,FT3和Logistic回归分析模型诊断LVDD的曲线下面积为0.742和0.858;FT3的临界值取3.37 pmol/L时,其提示患者出现LVDD的灵敏度为66.2%,特异度为75.0%。结论:老年男性T2DM患者的FT3水平降低时,LVDD风险上升,检测FT3可能有助于早期筛查LVDD。
关键词: 2型糖尿病; 左心室舒张功能不全; 游离三碘甲状腺原氨酸
缪婕, 王巍, 赵雅洁, 张凤如, 沈琳辉 . 老年男性2型糖尿病患者游离三碘甲状腺原氨酸水平与左心室舒张功能不全相关[J]. 诊断学理论与实践, 2024 , 23(02) : 155 -161 . DOI: 10.16150/j.1671-2870.2024.02.009
Object To explore the relationship between free triiodothyronine (FT3) level and left ventricular diastolic dysfunction(LVDD) in elderly male patients with type 2 diabetes mellitus. Methods A total of 208 elderly male (≥60 years) hospitalized patients with T2DM in Ruijin Hospital Shanghai Jiao Tong University School of Medicine were enrolled from January 2020 to November 2021. According to the Echocardiographic Assessment of Heart Disease for Systolic and Diastolic Function 2020, patients were divided into LVDD group (112 cases) and normal left ventricular fuction (control group, 96 cases). Baseline data, echocardiographic indicators, thyroid hormone indicators and thyroid hormone levels between 2 groups were compared. Meanwhile, all the patients were also divided into 4 groups according to the quartile level of FT3: F1 group (2.43 pmol/L<FT3≤3.30 pmol/L, n=52); F2 group (3.31 pmol/L<FT3≤3.78 pmol/L, n=52); F3 group(3.78 pmol/L<FT3≤4.65 pmol/L, n=52) and F4 group (4.66 pmol/L<FT3≤6.01 pmol/L, n=52). Baseline data and echocardiographic indicators were compared between the four groups. Pearson correlation was used to analyze the correlation between FT3 and echocardiographic indicators. Multivariate logistic regression analysis was used to explore the relationship between FT3 level and LVDD. Receiver operating characteristic (ROC) curve was used to evaluate the efficacy of FT3 and multivariate logistic regression model for diagnosing LVDD. Results Compared with the control group, the level of FT3 were significantly lower in LVDD group [(3.51±0.24)pmol/L vs (4.72±0.33) pmol/L, P<0.01]. Echocardiographic indicators showed that the percentage of LVDD, ratio of peak flow velocity E peak in early diastole in mitral orifice and peak flow velocity E peak in early diastole in mitral annulus (E/e’) were significantly different (P<0.01) in the four groups by the quartile level of FT3. Pearson correlation analysis showed that FT3 was negatively correlated with E/e’ (P<0.001) and left atrial volume index (P<0.001). Multivariate logistic regression analysis showed that as the quartile level of FT3 decreased, the risk of LVDD gradually increased (F3: OR=2.29; F2: OR=3.36; F1: OR=4.95; all P<0.05). Age, glycosylated hemoglobin (HbA1c), duration of diabetes mellitus and FT3 were entered into the logistic regression analysis model. ROC results showed the AUC of FT3 and multivariate logistic regression model for diagnosing LVDD were 0.742 and 0.858,respectively.When cutoff of FT3 was taken as <3.37 pmol/L,the sensitivity and specificity for diagnosing LVDD were 66.2% and 75.0%,respectively. Conclusions The risk of LVDD increases as FT3 level decreases in elderly male patients with T2DM, and FT3 may serve as a biomarker for early diagnosing LVDD.
[1] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4):315-409. |
Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chin J Diabete, 2021, 13(4):315-409. | |
[2] | BOONMAN-DE WINTER L J, RUTTEN F H, CRAMER M J, et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes[J]. Diabetologia, 2012, 55(8):2154-2162. |
[3] | ERNANDE L, AUDUREAU E, JELLIS C L, et al. Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus[J]. J Am Coll Cardiol, 2017, 70(14):1704-1716. |
[4] | THOMAS L, MARWICK T H, POPESCU B A, et al. Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2019, 73(15):1961-1977. |
[5] | 中华医学会超声医学分会超声心动图学组, 中国医师协会心血管分会超声心动图专业委员会. 超声心动图评估心脏收缩和舒张功能临床应用指南[J]. 中华超声影像学杂志, 2020, 29(6):461-477. |
Echocardiogram Group, Ultrasound Medicine Branch, Chinese Medical Association; Echocardiogram Professional Committee of the Cardiovascular Branch of the Chinese Medical Association. Guidelines for the clinical application of echocardiography in the assessment of cardiac systolic and diastolic function[J]. Chinese Journal of Ultrasound Imaging, 2020, 25(6): 461-477. | |
[6] | WANG W, WANG S, ZHANG K, et al. Hypothyroidism is associated with clinical outcomes in patients with acute myocardial infarction: subgroup analysis of China PEACE study[J]. Endocrine, 2021, 74(1):128-137. |
[7] | VALE C, NEVES J S, VON HAFE M, et al. The role of thyroid hormones in heart failure[J]. Cardiovasc Drugs Ther, 2019, 33(2):179-188. |
[8] | SATO Y, YOSHIHISA A, KIMISHIMA Y, et al. Low T3 syndrome is associated with high mortality in hospitali-zed patients with heart failure[J]. J Card Fail, 2019, 25(3):195-203. |
[9] | DANZI S, KLEIN I. Thyroid abnormalities in heart failure[J]. Cardiol Clin, 2022, 40(2):139-147. |
[10] | KANNAN L, SHAW P A, MORLEY M P, et al. Thyroid dysfunction in heart failure and cardiovascular outcomes[J]. Circ Heart Fail, 2018, 11(12):e005266. |
[11] | 黄瑄, 郑刚. 血清甲状腺素及心房利钠肽水平与冠心病患者左心室舒张功能的相关性[J]. 中国心血管病研究, 2016, 14(3):234-236. |
HUANG X, ZHENG G. The clinical correlations of the thyroid of hormone, natriuretic peptides and the left ventricular diastolic dysfunction[J]. Chin J Cardiovasc Res, 2016, 3(14):234-236 | |
[12] | LEITE A R, NEVES J S, ANGéLICO-GON?ALVES A, et al. Clinical and pathophysiologic insights of free triiodothyronine/free thyroxine ratio in patients with heart fai-lure with preserved ejection fraction: data from the NETDiamond Cohort[J]. Cardiology, 2023, 148(3):239-245. |
[13] | CAPPOLA A R, ARNOLD A M, WULCZYN K, et al. Thyroid function in the euthyroid range and adverse outcomes in older adults[J]. J Clin Endocrinol Metab, 2015, 100(3):1088-1096. |
[14] | MITCHELL J E, HELLKAMP A S, MARK D B, et al. Thyroid function in heart failure and impact on mortality[J]. JACC Heart Fail, 2013, 1(1):48-55. |
[15] | MANCINI A, DI SEGNI C, RAIMONDO S, et al. Thyroid hormones, oxidative stress, and inflammation[J]. Mediators Inflamm, 2016, 2016:6757154. |
[16] | SHARP A S, TAPP R J, THOM S A, et al. Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy[J]. Eur Heart J, 2010, 31(6):747-752. |
[17] | WU V C, HUANG Y C, WANG C L, et al. Association of echocardiographic parameter e/e' with cardiovascular events in a diverse population of inpatients and outpatients with and without cardiac diseases and risk factors[J]. J Am Soc Echocardiogr, 2023, 36(3):284-294. |
[18] | PLAYFORD D, STRANGE G, CELERMAJER D S, et al. Diastolic dysfunction and mortality in 436 360 men and women: the National Echo Database Australia (NEDA)[J]. Eur Heart J Cardiovasc Imaging, 2021, 22(5):505-515. |
/
〈 |
|
〉 |